BMS France and patient organization groups collaborate to create report on French blood transfusion landscape

In France, medical needs account for 10,000 blood donations a day. Most of the patients receiving these transfusions are over 65 years old.

Bristol Myers Squibb in France has partnered with the patient advocacy groups Connaître et Combattre les Myélodysplasies, l’Association Française de Lutte contre les Thalassémies and SOS Globi to develop a report about the French blood transfusion landscape, that includes recommendations for a better management of patient care in this area. More than ten stakeholders were involved in the development of this report. Currently, other patient organizations and healthcare professionals are invited to endorse the report and its recommendations. The next step will be to present this report to a larger audience in order to increase awareness around the topic and the shared recommendations. You find the report here (in French).4

Stay up to date

    © CSL 2026

    Blood & Beyond is a multi-stakeholder initiative funded by CSL, involving experts from the fields of haematology, transfusion medicine, anaesthesiology, patient blood management, nursing, patient advocacy, health economics, and hospital management, with support from policymakers committed to driving improvements in this area. The aim of the initiative is to raise awareness of the importance of good blood health and of the impact of anaemia on patients, healthcare systems and society at large, with the overarching goal to help advance policies and practices that improve patient outcomes by supporting patient-centricity in anaemia prevention, diagnosis, and management through patient blood management (PBM) and innovation.

    Contact

    For further information and queries, please contact the Blood and Beyond Secretariat: javier.lopezpanos@dgagroup.com

    Privacy Preference Center